FDA Strictly Limits Use of Johnson & Johnson’s COVID-19 Vaccine Due to Blood Clot Risk

FDA announced that it was strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to the risk of blood clots, a potentially life-threatening side effect. Regulators added warnings about a neurological reaction called Guillain-Barré syndrome.